New AI platform aids early screening of Alzheimer's disease

On the 7th, Harbin Medical University reported that the research team led by professors Zhou Qin and Cui Feiyun has integrated artificial intelligence (AI) into surface-enhanced Raman spectroscopy detection and blood metabolite analysis technology, developing a new blood metabolite molecular analysis testing platform, opening up a new technical pathway for minimally invasive blood screening for Alzheimer’s disease. The relevant research results were published in the international journal Analytical Chemistry (Science and Technology Daily).
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned